Medicine

GSK scandal should prompt China to reflect on wider pharma corruption

GSK scandal should prompt China to reflect on wider pharma corruption

By William Hao Wei Yang

As a new head of operations works out how best to guide GlaxoSmithKline’s China operation through a bribery scandal that has hit the world's headlines, industry watchers have have said the company is just the tip of the iceberg in a pharmaceutical...

Regulations are anything but complementary

Guest voice

Regulations are anything but complementary

By Dr Wendy Morrow, executive director, Complementary Healthcare Council of Australia

Something is not right when regulators increasingly opt to assess complementary medicines against medical criteria—in much the same way as pharmaceutical drugs are assessed.